A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
Clinical trial NCT04901195 · COMPLETED
Trial details
- NCT number
- NCT04901195
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2026-07-22
- Enrollment
- 658
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.